Theravance Biopharma, Inc. Increase (Decrease) in Other Receivables
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Other Receivables of $906.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2015-03-13
- Theravance Biopharma, Inc. increase (decrease) in other receivables for the quarter ending 2014-12-31 was $1.66M.
- Theravance Biopharma, Inc. increase (decrease) in other receivables for the quarter ending 2014-09-30 was $179.00K, a 135.53% increase year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in other receivables for the quarter ending 2014-06-30 was -$88.00K.
- Theravance Biopharma, Inc. increase (decrease) in other receivables for the quarter ending 2014-03-31 was -$844.00K, a 182.58% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in other receivables for fiscal 2014 was $906.00K.
- Theravance Biopharma, Inc. increase (decrease) in other receivables for fiscal 2013 was -$7.00K, a 101.13% decline from fiscal 2012.
- Theravance Biopharma, Inc. increase (decrease) in other receivables for fiscal 2012 was $617.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2014-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.84M derived: sum of 2 quarters · filed 2015-03-13 | $1.75M derived: sum of 3 quarters · filed 2015-03-13 | $906.00K 10-K · filed 2015-03-13 |
| 2014-09-30 | $179.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $91.00K derived: sum of 2 quarters · filed 2014-11-12 | -$753.00K 10-Q · filed 2014-11-12 | -$1.79M derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$932.00K 10-Q · filed 2014-08-14 | -$1.97M derived: sum of 3 quarters · filed 2015-03-13 | -$1.89M derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-03-31 | -$844.00K 10-Q · filed 2014-06-24 | -$1.88M derived: sum of 2 quarters · filed 2015-03-13 | -$1.81M derived: sum of 3 quarters · filed 2015-03-13 | -$1.87M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$962.00K derived: sum of 2 quarters · filed 2015-03-13 | -$1.03M derived: sum of 3 quarters · filed 2015-03-13 | -$7.00K 10-K · filed 2015-03-13 |
| 2013-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $9.00K derived: sum of 2 quarters · filed 2014-11-12 | $1.03M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $955.00K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $1.02M 10-Q · filed 2014-06-24 | |||
| 2012-12-31 | $617.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |